Cookie Consent by Privacy Policies website
Back to Elevai Labs

Investors

We rely on the capital markets for the growth of our brands.

View Stock Data

Latest Press Releases

View All
November 22, 2024

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

November 22, 2024

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

November 14, 2024

Elevai Labs Inc. Reports Financial Results for the Third Fiscal Quarter of 2024 and Provides Business Update

Track all markets on TradingView
Elevai Labs Inc. (NASDAQ: ELAB) specializes in medical aesthetics and biopharmaceutical drug development, focusing on aesthetic innovations for skin, and treatments tied to obesity and metabolic health. Driven by a commitment to scientific research, we aim to transform personal health and beauty.
Pages
IR HomePress ReleasesFAQManagementStock DataContact
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Download Presentation
Copyright ©ElevaiLabs.
Privacy policyTerms and Conditions